Persistence of humoral immune response to SARS-CoV-2 up to 7 months post-infection: Cross-sectional study, South India, 2020–21. Issue 3 (September 2021) - Thangaraj, Jeromie Wesley Vivian
Highlights: Few studies are available about persistence of SARS-CoV-2 antibodies from LMICs. Anti-nucleocapsid antibodies waned over a 7 month period post SARS-CoV-2 infection. Anti S1-RBD antibodies were relatively stable. Neutralizing antibodies were persistent up to seven months post-infection.